SION · Categories · Downgrades
SION - Analyst downgrades
Sionna Therapeutics Inc. (SION) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for SION
- Sionna Therapeutics downgraded by BTIG ResearchBTIG Research downgraded Sionna Therapeutics from Buy to Neutral
- Sionna Therapeutics downgraded by GuggenheimGuggenheim downgraded Sionna Therapeutics from Buy to Neutral
- Sionna Therapeutics downgraded by CitizensCitizens downgraded Sionna Therapeutics from Mkt Outperform to Mkt Perform
- Sionna Therapeutics downgraded by Raymond JamesRaymond James downgraded Sionna Therapeutics from Strong Buy to Mkt Perform
- Sionna Therapeutics downgraded by Wedbush with a new price targetWedbush downgraded Sionna Therapeutics from Outperform to Neutral and set a new price target of $5.00
- Sionna Therapeutics downgraded by Stifel with a new price targetStifel downgraded Sionna Therapeutics from Buy to Hold and set a new price target of $7.00
- Sionna Therapeutics downgraded by RBC Capital Mkts with a new price targetRBC Capital Mkts downgraded Sionna Therapeutics from Sector Perform to Underperform and set a new price target of $24.00
Other SION categories
Is something on this page wrong? Request a change